162 related articles for article (PubMed ID: 5567294)
1. Quipazine, a new type of antidepressant agent.
Rodríguez R; Pardo EG
Psychopharmacologia; 1971; 21(1):89-100. PubMed ID: 5567294
[No Abstract] [Full Text] [Related]
2. Effect of acylation with eleostearic acids on the monoamine oxidase inhibitory potency of some hydrazine antidepressants in mice.
Hsu SY; Huang CL; Waters IW
J Med Chem; 1975 Jan; 18(1):20-3. PubMed ID: 1109570
[TBL] [Abstract][Full Text] [Related]
3. Phenacylthioimidazolines and 3-aryl-5,6-dihydroimidazo(2,1-b)thiazoles with antidepressant activity.
Sharpe CJ; Shadbolt RS; Ashford A; Ross JW
J Med Chem; 1971 Oct; 14(10):977-82. PubMed ID: 5165571
[No Abstract] [Full Text] [Related]
4. A possible interaction of quipazine with central dopamine structures.
Grabowska M; Antkiewicz L; Michaluk J
J Pharm Pharmacol; 1974 Jan; 26(1):74-6. PubMed ID: 4150944
[No Abstract] [Full Text] [Related]
5. Inactivity of delta9-tetrahydrocannabinol in antidepressant screening tests.
Sofia RD; Kubena RK; Barry H
Psychopharmacologia; 1973 Jul; 31(2):121-30. PubMed ID: 4722206
[No Abstract] [Full Text] [Related]
6. Animal models used in prediction of antidepressant effects in man.
Cooper BR; Howard JL; Soroko FE
J Clin Psychiatry; 1983 May; 44(5 Pt 2):63-6. PubMed ID: 6406466
[TBL] [Abstract][Full Text] [Related]
7. The influence of quipazine on the turnover rate of serotonin.
Grabowska M; Antkiewicz L; Michaluk J
Biochem Pharmacol; 1974 Nov; 23(22):3211-2. PubMed ID: 4441411
[No Abstract] [Full Text] [Related]
8. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
Hoffmeister F
Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
[No Abstract] [Full Text] [Related]
9. Antidepressant properties of 2-(4-ethyl-1-piperazinyl)-4-phenylquinoline hydrochloride (AD-1308) and its mechanism of action as compared with tricyclic antidepressants.
Karasawa T; Furukawa K; Ochi Y; Ito T; Yoshida K; Shimizu M
Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):283-302. PubMed ID: 6773486
[No Abstract] [Full Text] [Related]
10. N-Phenyl-2-indolinones and N-phenylindolines. A new class of antidepressant agents.
Cañas-Rodriguez A; Leeming PR
J Med Chem; 1972 Jul; 15(7):762-70. PubMed ID: 5043876
[No Abstract] [Full Text] [Related]
11. Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.
Soroko FE; Mehta NB; Maxwell RA; Ferris RM; Schroeder DH
J Pharm Pharmacol; 1977 Dec; 29(12):767-70. PubMed ID: 22628
[No Abstract] [Full Text] [Related]
12. Pharmacology of clovoxamine, a new non-tricyclic antidepressant.
Claassen V; Boschman TA; Dhasmana KM; Hillen FC; Vaatstra WJ; Zwagemakers JM
Arzneimittelforschung; 1978; 28(10):1756-66. PubMed ID: 582680
[No Abstract] [Full Text] [Related]
13. Narcotic agonists and antagonists as models for potential antidepressant drugs.
Doggett NS; Reno H; Spencer PS
Neuropharmacology; 1975 Jul; 14(7):507-15. PubMed ID: 1153093
[No Abstract] [Full Text] [Related]
14. Quipazine: its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour.
Green AR; Youdim MB; Grahame-Smith DG
Neuropharmacology; 1976 Mar; 15(3):173-9. PubMed ID: 132619
[No Abstract] [Full Text] [Related]
15. Quipazine induced wet dog shake behaviour in rats: mechanism of action.
Hiremagalur ; Keshavan JH; Dandiya PC; Gurbani NK
Pharmacol Res Commun; 1980 Sep; 12(8):757-68. PubMed ID: 6160597
[No Abstract] [Full Text] [Related]
16. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of psychostimulant 2-phenyl-5,5-dimethyl-tetrahydro-1,4-oxazine hydrochloride (G 130) to central nervous system depressing drugs. Monoamine oxidase inhibitory activity and norepinephrine and serotonin induced changes. Comparison with dL-amphetamine.
Fanelli O; Mazzoncini V; Trallori L
Arzneimittelforschung; 1974 Dec; 24(12):2025-9. PubMed ID: 4480283
[No Abstract] [Full Text] [Related]
18. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
Fuller RW; Snoddy HD; Mason NR; Hemrick-Luecke SK; Clemens JA
J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711
[No Abstract] [Full Text] [Related]
19. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
Proctor CD; Kirby J; Wood MH; Wade LH; King PK
Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
[No Abstract] [Full Text] [Related]
20. Substituted tetrahydrofurfurylamines as potential antidepressants.
Monkovic I; Perron YG; Martel R; Simpson WJ
J Med Chem; 1973 Apr; 16(4):403-7. PubMed ID: 4716185
[No Abstract] [Full Text] [Related]
[Next] [New Search]